Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Fc gamma receptor (FcγR) family consists of several cell surface glycoproteins that bind the Fc region of immunoglobulin G (IgG) antibodies, serving as a critical link between the adaptive and innate immune systems (Source: UniProt). These receptors are categorized into three main classes—FcγRI (CD64), FcγRII (CD32), and FcγRIII (CD16)—which are further divided into activating and inhibitory types based on their signaling motifs (Source: PMC4102151). Activating receptors, such as FcγRIIIa, mediate essential immune functions like antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis, while the inhibitory receptor FcγRIIb acts as a checkpoint to maintain immune homeostasis. In oncology, many therapeutic monoclonal antibodies are designed to optimize binding to activating}
Engagement of activating receptors (FcγRI, FcγRIIa, FcγRIIIa) to trigger antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis (ADCP); competitive inhibition of IgG binding to prevent tissue destruction; and modulation of the inhibitory receptor FcγRIIb to regulate B-cell signaling and inflammatory responses (Source: PMC4102151, StatPearls).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fc gamma receptor family (FcγR).